The solid progress of nanomedicine

Martins, J. P.; das Neves, J.; De La Fuente Freire, María; Celia, C.; Florindo, H.; Guenday-Tureli, N.; Popat, A.; Santos, J. L.; Sousa, F.; Schmid, R.; Wolfram, J.; Sarmento, B.; Santos, H. A.
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/16671
PMID: 32141035
ISSN: 2190-393X
Full record
Services
Services
RISMendeleyLinksolver
Files view or download
Files view or download
Date issued
2020
Journal title
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
Type of content
Journal Article
DeCS
grupos focales | nanomedicina | humanos | neoplasias | National Cancer Institute (U.S.)
MeSH
National Cancer Institute (U.S.) | Humans | Nanomedicine | Focus Groups | Neoplasms
Abstract
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.
Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional